<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Moderna Inc (NASDAQ: MRNA) is now in the “oversold” territory after a 65% hit to its stock price over the past six months, says Sanctuary Wealth’s chief investment officer. Why Kilburg likes Moderna On CNBC’s “Power Lunch”, Jeff Kilburg said he was interested in owning Moderna on sale as the company had promising prospects for […] The post Moderna receives full FDA approval: is it time to buy the stock?
...read full article on Invezz
